Our work on dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration, is accepted for publication in International Journal of Pharmaceutics. This work is in collaboration with Dr. Shuofeng Yuan from the HKU Department of Microbiology. Congrats to Han Cong and the team!
Kommentare